Stock ScreenerStock IdeasHigh Risk, High RewardHigh Risk, High Reward StocksSpeculative companies with the highest upside potential according to WallStreet analysts. Proceed with extreme caution!
Stock ScreenerStock IdeasHigh Risk, High Reward
Consensus: Strong Buy + 1 more
Analysts: >= 2
Upside/Downside: >= 500%
| Ticker | Company | Zen Rating | Sentiment | Market Cap | Shares | Institutional % | Insider % | Net Insider (L12M) | Net Insider (L3M) |
|---|---|---|---|---|---|---|---|---|---|
| KALA | KALA BIO INC | $5.54M | 8,209,725 | 3.32% | 96.68% | Net Selling | Net Selling | ||
| FBLG | FIBROBIOLOGICS INC | $20.22M | 51,456,077 | 10.48% | 12.05% | Net Buying | Net Buying | ||
| CANF | CAN-FITE BIOPHARMA LTD | $3.37M | 3,967,407,393 | 0.04% | 0.00% | ||||
| NRXP | NRX PHARMACEUTICALS INC | $58.16M | 28,097,627 | 7.36% | 92.64% | Net Buying | |||
| ACET | ADICET BIO INC | $76.47M | 153,255,581 | 33.50% | 10.89% | Net Buying | Net Buying | ||
| SGMO | SANGAMO THERAPEUTICS INC | $151.42M | 336,494,489 | 18.60% | 9.54% | Net Selling | Net Selling | ||
| SKYE | SKYE BIOSCIENCE INC | $34.94M | 32,057,461 | 2.73% | 97.27% | Net Selling | |||
| BTAI | BIOXCEL THERAPEUTICS INC | $43.96M | 21,869,491 | 1.18% | 98.82% | Net Selling | |||
| PHIO | PHIO PHARMACEUTICALS CORP | $12.06M | 10,764,428 | 0.18% | 99.82% | Net Buying | Net Buying | ||
| MBRX | MOLECULIN BIOTECH INC | $10.14M | 2,036,419 | 10.88% | 89.12% | Net Buying | Net Selling | ||
| VNRX | VOLITIONRX LTD | $33.03M | 122,801,572 | 21.27% | 31.03% | Net Buying | Net Buying | ||
| LSTA | LISATA THERAPEUTICS INC | $17.64M | 8,820,733 | 0.84% | 99.16% | Net Selling | |||
| RCKT | ROCKET PHARMACEUTICALS INC | $366.87M | 108,222,228 | 50.65% | 49.35% | Net Selling | Net Selling | ||
| NAKA | KINDLY MD INC | $175.94M | 439,850,889 | 24.72% | 5.85% | Net Buying | |||
| TVRD | TVARDI THERAPEUTICS INC | $41.37M | 9,381,344 | 7.84% | 92.16% | Net Selling | |||
| ENLV | ENLIVEX THERAPEUTICS LTD | $22.57M | 24,292,833 | 3.72% | 59.15% | ||||
| PSTV | PLUS THERAPEUTICS INC | $94.00M | 137,429,055 | 3.79% | 17.25% | Net Buying | Net Buying | ||
| OSTX | OS THERAPIES INC | $63.74M | 35,214,352 | 4.44% | 18.75% | Net Selling | |||
| IMUX | IMMUNIC INC | $74.82M | 120,284,724 | 35.49% | 13.20% | Net Buying | |||
| SLN | SILENCE THERAPEUTICS PLC | $298.22M | 141,701,848 | 13.91% | 0.09% | ||||
| IFRX | INFLARX NV | $71.13M | 67,747,130 | 27.40% | 0.00% | ||||
| PDSB | PDS BIOTECHNOLOGY CORP | $47.71M | 48,980,307 | 11.47% | 24.13% | Net Buying | |||
| KRRO | KORRO BIO INC | $77.50M | 9,417,295 | 25.74% | 74.26% | ||||
| ONCY | ONCOLYTICS BIOTECH INC | $102.91M | 103,635,734 | 2.72% | 0.00% | ||||
| AKTX | AKARI THERAPEUTICS PLC | $27.81M | 71,479,461,523 | 0.00% | 6.24% | Net Buying | Net Buying | ||
| FEMY | FEMASYS INC | $50.12M | 58,479,824 | 6.42% | 4.05% | Net Buying | |||
| CING | CINGULATE INC | $30.00M | 6,757,070 | 3.76% | 96.24% | ||||
| ATYR | ATYR PHARMA INC | $75.94M | 97,986,634 | 63.19% | 15.70% | Net Buying | Net Buying | ||
| PMN | PROMIS NEUROSCIENCES INC | $19.35M | 2,152,444 | 23.87% | 76.13% | Net Buying | Net Buying | ||
| ZSPC | ZSPACE INC | $14.61M | 29,050,067 | 1.28% | 98.72% | Net Selling | Net Selling | ||
| SNTI | SENTI BIOSCIENCES INC | $34.44M | 26,290,838 | 18.58% | 81.42% | Net Buying | |||
| CTSO | CYTOSORBENTS CORP | $42.96M | 62,804,305 | 26.01% | 45.21% | Net Buying | Net Buying | ||
| RANI | RANI THERAPEUTICS HOLDINGS INC | $162.83M | 121,511,580 | 3.32% | 33.62% | Net Selling | Net Selling | ||
| AMTX | AEMETIS INC | $96.39M | 65,568,542 | 8.46% | 91.54% | Net Buying | |||
| ZYXI | ZYNEX INC | $22.49M | 30,388,635 | 12.84% | 46.66% | Net Selling | |||
| CYBN | CYBIN INC | $153.86M | 23,033,127 | 39.83% | 0.00% | ||||
| MYO | MYOMO INC | $40.36M | 38,435,524 | 35.34% | 11.08% | Net Buying | Net Buying | ||
| RZLT | REZOLUTE INC | $166.91M | 92,727,532 | 44.67% | 55.33% | Net Buying | |||
| HUMA | HUMACYTE INC | $245.33M | 187,271,321 | 24.49% | 16.42% | Net Selling | |||
| CODX | CO-DIAGNOSTICS INC | $20.76M | 60,892,582 | 9.23% | 17.44% | Net Selling | Net Selling | ||
| TNYA | TENAYA THERAPEUTICS INC | $141.53M | 166,505,885 | 20.74% | 22.99% | Net Buying | Net Selling | ||
| JSPR | JASPER THERAPEUTICS INC | $49.53M | 27,984,039 | 29.25% | 70.75% | Net Buying | Net Buying | ||
| TCRX | TSCAN THERAPEUTICS INC | $57.32M | 56,747,993 | 60.97% | 29.87% | Net Buying | |||
| CLGN | COLLPLANT BIOTECHNOLOGIES LTD | $20.73M | 11,454,512 | 13.19% | 0.00% | ||||
| CABA | CABALETTA BIO INC | $227.19M | 96,265,204 | 71.90% | 4.39% | ||||
| MGX | METAGENOMI INC | $61.95M | 37,546,751 | 15.98% | 34.26% | Net Buying | Net Buying |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.